The clinical performance is complex and often involves multi-systematic fatigue. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of IBD requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised development of treatment programs for the treatment and management of IBD requires multiple-dimensional management, typically including drug therapy, rehabilitation intervention, lack of regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many infectious respiratory digestive endocrine disorders that were previously difficult to treat have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of IBD-associated folic acid deficiency. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.